Intervention Protocol

Psychodynamic therapies versus treatment as usual for depression

  1. Theresa HM Moore1,
  2. Vivien Hunot1,
  3. Philippa Davies1,
  4. Deborah Caldwell2,
  5. Hannah Jones3,
  6. Glyn Lewis2,
  7. Rachel Churchill1,*

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 8 SEP 2010

DOI: 10.1002/14651858.CD008707


How to Cite

Moore THM, Hunot V, Davies P, Caldwell D, Jones H, Lewis G, Churchill R. Psychodynamic therapies versus treatment as usual for depression (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 9. Art. No.: CD008707. DOI: 10.1002/14651858.CD008707.

Author Information

  1. 1

    University of Bristol, Academic Unit of Psychiatry, School of Social and Community Medicine, Bristol, UK

  2. 2

    University of Bristol, School of Social and Community Medicine, Bristol, Avon, UK

  3. 3

    The University of Nottingham, Cochrane Schizophrenia Group, Nottingham, UK

*Rachel Churchill, Academic Unit of Psychiatry, School of Social and Community Medicine, University of Bristol, Cotham House, Cotham Hill, Bristol, BS6 6JL, UK. rachel.churchill@ccdan.org. rachel.churchill@bristol.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 SEP 2010

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  1. To examine the effectiveness and acceptability of all psychodynamic therapies compared with treatment as usual/waiting list/attention placebo control conditions for acute depression.
  2. To examine the effectiveness and acceptability of different psychodynamic therapy models (drive/structural, relational and integrative analytic models) compared with treatment as usual/waiting list/attention placebo control conditions for acute depression.
  3. To examine the effectiveness and acceptability of all psychodynamic therapies compared with different types of comparator (standard care, no treatment, waiting list, attention placebo) for acute depression.